Cognitive Health Market Analysis
This report highlights the companies doing cognitive health testing, detection and diagnosis of neurodegenerative diseases. Some of the technologies that the companies identified leverage include Artificial Intelligence, Artificial Reality, Eye Screening, Biomarker Detection Tools, and digital platforms.
Twenty plus companies were analyzed as part of this report. Of the 22, 10 were listed as ‘Top Companies’. These companies were given this distinction because they had the most robust cognitive testing and assessment technologies and methodologies coupled with strong market positioning. The top companies not only exhibited robust product development and technology usage, but also had key partnerships with various institutions to further strengthen their reach.
Top companies in report include:
Altoida
Altoida offers a medical diagnostic application designed to detect Alzheimer’s and dementia prior to its onset using augmented reality. The company’s application tests the functional and cognitive aptitude of a patient, via a machine-learning algorithm, and offers a methodology based on longitudinal clinical studies. Altoida is building a leading platform to accelerate and improve drug development, research, and care for people with neurological diseases. Through a set of tasks that simulate activities of daily living, Altoida’s software medical device for cognitive assessment puts personalized and actionable brain health measurements in the hands of patients, providers, and researchers.
Altoida measures 250 functions that can be connected to cognitive decline, generated from sensor data. Altoida is accelerating and improving the development, research, and care for people with neurological diseases by using data that is captured with a standard smartphone or tablet. Conventional biomarkers and assessments are unreliable and expensive, but Altoida is filling that gap by making it more reliable, affordable, and accessible. Altoida’s medical device for cognitive assessment measures brain health in 10 minutes with a battery of immersive augmented reality (AR) activities.
Neurotrack
Neurotrack is a California-based company that develops digital health platforms designed to help people to build, change and track healthy behaviors. Neurotrack develops digital cognitive health solutions that enable people to assess, monitor, and strengthen their brain health to reduce the risk of Alzheimer’s and other dementias. Neurotrack’s solutions are built on a digital platform, enabling convenient and remote cognitive testing from the privacy of home. Neurotrack’s approach is focused on preserving and strengthening cognitive health now as opposed to managing its decline later. Neurotrack’s products are available to businesses, researchers, and health organizations to provide to individuals.
Neurotrack features a range of highly regarded academic reserach partners. Neurotrack leverages the latest neuroscience and technology to make remote testing accurate and accessible. Neurotrack uses the latest neuroscience and technology to develop digital assessments that reliably and remotely assess one’s current cognitive condition. The company’s platform offers cognitive health programs to assess, preserve and strengthen memory health, enabling individuals to manage their brain health and reduce their risk of cognitive decline in the future.
Savonix
Savonix provides a virtual neuropsychologist platform designed to assess and monitor cognitive health. The company’s platform delivers a mobile, evidence-based assessment of cognitive and emotional function and provides an accurate, accessible, real-time monitoring tool for professional cognitive screening of dementia. The Savonix mobile platform analyzes cognition — the mental process of acquiring knowledge and understanding through our thoughts, experiences, and senses. Savonix features 13 cognitive domains along which they assess brain function. Savonix also features more than 50M data points and 1000s of cognitive data profiles that provide detailed app-behavioral insights into test performance and cognition.
Savonix has a growing database of over 50 million data points that can be leveraged for research. Built from the ground up on a mobile platform, Savonix delivers the first scientifically proven, consumer-style app that provides valuable information about brain health and wellness. They assess many areas of cognition with game-like versions of gold-standard neurocognitive tests. Used in thousands of research studies worldwide, these tests have been shown to predict the development of dementia and to track symptoms such as memory and executive function in other disorders like depression and diabetes.
